Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vandana S. Mathur is active.

Publication


Featured researches published by Vandana S. Mathur.


American Journal of Kidney Diseases | 1997

Polyomavirus-induced interstitial nephritis in two renal transplant recipients: Case reports and review of the literature

Vandana S. Mathur; Jean L. Olson; Teresa M. Darragh; T.S. Benedict Yen

We present two case reports of renal polyomavirus infection leading to renal allograft dysfunction, review the literature of this entity, and discuss the role of specific immunosupressives. Histologically, the virus caused an interstitial infiltrate composed of plasma cells and lymphocytes, interstitial fibrosis, and tubular atrophy. Viral inclusions were seen within tubular cells on light microscopy. Electron microscopy showed viral particles of 40 to 50 nm in a characteristic paracrystalline array. Both patients had been on FK-506-based immunosuppression. In both patients, the virus appeared to clear histologically and renal function stabilized when the patients were converted to cyclosporine-based immunosuppression. Contrary to prior reports, our patients have not lost their grafts and continue to have stable, albeit reduced, graft function at 2.5 years and 4.5 years following the initial diagnosis of renal polyomavirus infection.


Transplantation | 1997

Immunologic and patient selection strategies for successful utilization of less than 15 kg pediatric donor kidneys-long term experiences with 40 transplants

Peter N. Bretan; Christopher Friese; Ruth B. Goldstein; Robert W. Osorio; Stephen J. Tomlanovich; William Amend; Vandana S. Mathur; Flavio Vincenti

Renal transplantation using infant donors is associated with significantly less graft survival (GS) and increased morbidity, especially from very young and small donors. We report our results using specific strategies to determine which age and size donor require en bloc renal transplant reconstruction and associated immunologic protocols for optimization of subsequent GS. Forty cadaveric pediatric en bloc renal transplants were performed. Mean donor age was 23.6+/-18.4 months with subgroups: 2-12 months, n=14; 13-24 months, n=19; and 25-60 months, n=7. Mean donor weight was 14.4+/-4.5 kg. All kidneys were placed in primary, nonsensitized (peak PRA = 7.9+/-5.6%) adult (41.6+/-16 years) recipients. Low weight was preferred (62.4+/-12.8 kg). Mean cold ischemia time was 26.9+/-8.6 hr. Immunosuppression consisted of quadruple immunosuppression (QI) with OKT3 induction. All patients had ureteral stents placed intraoperatively. Mean follow-up was 16.9 months. Actuarial GS at 12, 24, and 33 months were 100% (n=13), 85% (n=20), and 71% (n=7), respectively. Total GS was 35/40=88%. All grafts functioned immediately and there were no technical losses. Biopsy proven rejections occurred in 12 (30%) patients, developing at 16-167 days postoperatively (mean = 50.3 days). Mean serum creatinine at one week and 1, 6, 12, and 18 months were 2.1+/-2.0, 1.5+/-0.8, 1.3+/-0.5, 1.1+/-0.4, and 0.9+/-0.4 mg/dl, respectively. Functional isotopic renography, as well as sonographic monitoring reflected rapid initial and continued growth in these kidneys. Mean BP at 12 and 24 months postoperatively were 145/83+/-18/13 and 122/76+/-20/10 mmHg, respectively, with no significant proteinuria noted. Excellent results with minimal complications utilizing very small and young infant donors can be achieved with QI immunosuppression, and selection of low immune reactive and noncomplicated adult recipients. Additionally, maximal renal dosing by minimizing recipient weight may prevent future hyperfiltration damage.


Pharmacotherapy | 1997

Pharmacokinetics of mycophenolate mofetil and intravenous ganciclovir alone and in combination in renal transplant recipients

Erika J. Wolfe; Vandana S. Mathur; Stephen J. Tomlanovich; Don Jung; Rodney Wong; Kay Griffy; Francesca T. Aweeka

Study Objectives. To evaluate the pharmacokinetics of mycophenolic acid and its glucuronide metabolite alone and in the presence of ganciclovir, and to determine the pharmacokinetics of ganciclovir alone and in combination with mycophenolate mofetil.


Mutation Research Letters | 1984

Effect of prior X-irradiation on ultraviolet light-induced sister-chromatid exchange

Robert B. Painter; Vandana S. Mathur

Induction of sister-chromatid exchanges (SCEs) by ultraviolet light at 2.6 J/m2 in Chinese hamster ovary cells was significantly inhibited by pretreatment with 3 and 5 Gy of X-rays. No inhibition was observed when cells were treated first with ultraviolet light and subsequently X-irradiated with 5 Gy.


Journal of Cardiac Failure | 2007

High Prevalence of Renal Dysfunction and Its Impact on Outcome in 118,465 Patients Hospitalized With Acute Decompensated Heart Failure: A Report From the ADHERE Database

J. Thomas Heywood; Gregg C. Fonarow; Maria Rosa Costanzo; Vandana S. Mathur; John R. Wigneswaran; Janet Wynne


Archive | 2005

Systems and methods for performing bi-lateral interventions or diagnosis in branched body lumens

Samir J. Patel; Harry B. Goodson; Jeffrey M. Elkins; Craig A. Ball; Vandana S. Mathur


Catheterization and Cardiovascular Interventions | 2001

Use of fenoldopam to prevent radiocontrast nephropathy in high‐risk patients

Hooman Madyoon; Linda Croushore; Douglas Weaver; Vandana S. Mathur


Academic Emergency Medicine | 2008

Fenoldopam, a Dopamine Agonist, for Hypertensive Emergency: A Multicenter Randomized Trial

James A. Tumlin; Lala M. Dunbar; Suzanne Oparil; Vardaman M. Buckalew; C. Venkata S. Ram; Vandana S. Mathur; David G. Ellis; Dawn McGuire; Jere Douglas Fellmann; Robert R. Luther


Nephrology Dialysis Transplantation | 2004

The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure

Javed Butler; Charles L. Emerman; W. Frank Peacock; Vandana S. Mathur; James B. Young


American Heart Journal | 2003

B-type natriuretic peptide: from bench to bedside.

Kirkwood F. Adams; Vandana S. Mathur; Mihai Gheorghiade

Collaboration


Dive into the Vandana S. Mathur's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dawn McGuire

University of California

View shared research outputs
Top Co-Authors

Avatar

Hooman Madyoon

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert R. Luther

University of Southern California

View shared research outputs
Top Co-Authors

Avatar

Samir J. Patel

Houston Methodist Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew T. Ho

Loma Linda University Medical Center

View shared research outputs
Top Co-Authors

Avatar

C. Venkata S. Ram

University of Texas Southwestern Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge